Trials / Unknown
UnknownNCT02394262
Sequential Coronary CT-angiography and Biomarkers
Prediction of Atherosclerotic Plaque Burden Progression With Sequential Coronary CT-angiography and Biomarkers
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Currently, cardiac computed tomography angiography (CCTA) is a well-implemented non-invasive diagnostic imaging modality in patients with stable chest pain. Besides conventional CT-reading, CCTA is also capable to identify several morphologic and geometric characteristics of atherosclerotic plaques. Recently, the investigators showed that the use of semi-automated plaque quantification algorithm identified parameters predictive for acute coronary syndrome on top of clinical risk profiling and conventional CT-reading. In addition, several atherotrombosis biomarkers, like high-sensitivity cardiac troponins, are described as related to coronary artery disease and cardiovascular events. Prospective data with sequential analysis of atherosclerotic plaques combined with different atherothrombosis biomarkers are currently lacking, but will provide important clues about the pathophysiology of plaque progression and atherothrombosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Coronary CT-angiography | Sequential CCTA after one year follow-up. The first CCTA will be performed in terms of diagnostic work-up (referral outpatient Cardiology department). |
| OTHER | Assesment of biomarkers involved in atherothrombosis | Sequential assesment of atherothrombis biomarkers: baseline and at 1 year follow-up. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2018-11-01
- Completion
- 2019-11-01
- First posted
- 2015-03-20
- Last updated
- 2017-03-28
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02394262. Inclusion in this directory is not an endorsement.